Indu Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 18-01-2025
- Paid Up Capital ₹ 8.10 M
as on 18-01-2025
- Company Age 20 Year, 5 Months
- Last Filing with ROC 31 Mar 2019
- Satisfied Charges ₹ 81.34 Cr
as on 18-01-2025
- Revenue 8.46%
(FY 2019)
- Profit 57.33%
(FY 2019)
- Ebitda 42.92%
(FY 2019)
- Net Worth -4.33%
(FY 2019)
- Total Assets -11.34%
(FY 2019)
About Indu Pharma
- CIN/LLPIN
U24239TG2004PTC043904
- Company No.
043904
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Aug 2004
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Indu Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sirish Ravula  | Director | 02-Aug-2006 | Current |
| Ravi Yerra | Director | 01-Jun-2011 | Current |
| Yogesh Krishna | Additional Director | 28-Dec-2018 | Current |
Financial Performance of Indu Pharma.
Indu Pharma Private Limited, for the financial year ended 2019, experienced modest growth in revenue, with a 8.46% increase. The company also saw a substantial improvement in profitability, with a 57.33% increase in profit. The company's net worth dipped by a decrease of 4.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indu Pharma?
In 2019, Indu Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Devi Pharmatech Private LimitedActive 4 years 3 monthsSirish Ravula and Ravi Yerra are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 27 Jun 2013 | ₹22.50 Cr | Satisfied |
State Bank Of India Creation Date: 27 Jun 2013 | ₹22.50 Cr | Satisfied |
State Bank Of India Creation Date: 01 Oct 2010 | ₹30.19 Cr | Satisfied |
How Many Employees Work at Indu Pharma?
Unlock and access historical data on people associated with Indu Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indu Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indu Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
